Flash News | Mabgeek Biotech Obtains Clinical Approval for EoE and PN Drugs
2024-09-27 0
Recently, the innovative monoclonal antibody drug "MG-K10 humanized monoclonal antibody injection" submitted by Mabgeek Biotech has obtained the drug clinical trial approval notice issued by the National Drug Evaluation Center. It is intended to be developed for the treatment of nodular prurigo (PN) and eosinophilic esophagitis (EoE). So far, MG-K10 humanized monoclonal antibody injection has obtained 5 drug clinical trial approval notices for indications.
Source: CDE official website